Reevaluation of nucleotide sequences of wild-type and attenuated polioviruses of type 3

• Published in: Virus research Vol. 65; no. 2; pp. 111 - 119
• Main Authors: Rezapkin, Gennady V., Douthitt, Monica, Dragunsky, Eugenia, Chumakov, Konstantin M.
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 15.12.1999
• Subjects: Animals; Attenuation; Base Sequence; Consumer Product Safety; Macaca mulatta; Mice; Mice, Transgenic; Neurovirulence; Oral poliovirus vaccine (OPV); Poliomyelitis - genetics; Poliomyelitis - pathology; Poliovirus; Poliovirus - genetics; Poliovirus - pathogenicity; Poliovirus Vaccine, Oral - adverse effects; Poliovirus Vaccine, Oral - genetics; Vaccine safety; Vaccines, Attenuated - adverse effects; Vaccines, Attenuated - genetics; Attenuation; Vaccine safety; Neurovirulence; Oral poliovirus vaccine (OPV)
• DOI: 10.1016/S0168-1702(99)00108-2
• ISSN: 0168-1702

Published sequences of wild-type and attenuated Sabin strains of type 3 poliovirus (Leon/37 and Leon 12a 1b) were derived from cDNA clones. Recent direct sequencing of Sabin 3 RNA showed that it differed from the published sequence in at least two sites. Here results of direct sequencing of genomes of three independently re-derived sub-strains of attenuated Sabin 3 poliovirus used for oral poliovirus vaccine (OPV) production in addition to the most widely used Pfizer sub-strain are reported. The results showed that all four sub-strains of attenuated type 3 poliovirus contain unique patterns of mutations. Two stocks of the wild-type progenitor Leon/37 strain were also sequenced. Analysis of the two samples of Leon/37 virus showed that one of them is much closer to the Sabin 3 strain, and is an intermediate product of the attenuation process. In addition, we created genetically engineered constructs which contained some of the mutations suspected for their possible role in neurovirulence, and tested them in monkeys and in transgenic mice sensitive to poliovirus. The results suggested that none of them increased neurovirulence of the virus, but some may improve virus replication. Therefore the only mutation occurring in Sabin 3 under vaccine production conditions that appears to affect neurovirulence of the virus is the well known U→C reversion at nucleotide 472.